IMV Profit margin
What is the Profit margin of IMV?
The Profit margin of IMV, Inc. is -11,547.11%
What is the definition of Profit margin?
Profit margin is a measure of profitability and is calculated by finding the net profit as a percentage of the revenue.
lfy (last fiscal year)
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Profit margin of companies in the Health Care sector on TSX compared to IMV
What does IMV do?
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Companies with profit margin similar to IMV
- Royal Helium has Profit margin of -11,870.97%
- Marmota has Profit margin of -11,866.67%
- Clean Power Hydrogen Plc has Profit margin of -11,846.43%
- Terramin Australia has Profit margin of -11,825.40%
- DGO Gold has Profit margin of -11,616.67%
- IGM Biosciences has Profit margin of -11,568.83%
- IMV has Profit margin of -11,547.11%
- Greenland Minerals has Profit margin of -11,528.30%
- Metalicity has Profit margin of -11,333.33%
- Horseshoe Metals has Profit margin of -11,285.71%
- Verona Pharma Plc has Profit margin of -11,276.86%
- Venus Metals has Profit margin of -11,195.65%
- Summit Therapeutics plc has Profit margin of -11,174.47%